Intraportal FK 506 improves intrahepatic islet allograft survival.
Wang
X
X
Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia.
Berezniak
R
R
Tafra
L
L
Posselt
A
A
Barker
C F
CF
Dafoe
D C
DC
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D019819:Budesonide; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use; D003921:Diabetes Mellitus, Experimental / Q000601:surgery*; D005938:Glucocorticoids / Q000627:therapeutic use; D006085:Graft Survival; D007275:Injections, Intravenous; D016381:Islets of Langerhans Transplantation / Q000276:immunology / Q000502:physiology*; D011169:Portal Vein; D011282:Pregnenediones / Q000008:administration & dosage / Q000627:therapeutic use; D051381:Rats; D011917:Rats, Inbred Lew; D011920:Rats, Inbred WF; D016559:Tacrolimus / Q000008:administration & dosage* / Q000627:therapeutic use; D014184:Transplantation, Homologous
D005938:Glucocorticoids; D011282:Pregnenediones; D019819:Budesonide; D016572:Cyclosporine; D016559:Tacrolimus